Your browser doesn't support javascript.
loading
Cost-effectiveness of therapeutic interventions in schizophrenia
Díaz-Castro, L; Cabello-Rangel, H; Arredondo, A; Madrigal de León, E; Pineda-Antúnez, C.
Affiliation
  • Díaz-Castro, L; National Institute of Public Health. Mexico
  • Cabello-Rangel, H; Psychiatric Hospital "Fray Bernardino Álvarez". Mexico
  • Arredondo, A; National Institute of Public Health. Cuernavaca. Mexico
  • Madrigal de León, E; University of Guadalajara. Mexico
  • Pineda-Antúnez, C; National Institute of Public Health. Cuernavaca. Mexico
Eur. j. psychiatry ; 31(1): 11-16, ene.-mar. 2017. tab, graf
Article in English | IBECS | ID: ibc-179644
Responsible library: ES1.1
Localization: BNCS
ABSTRACT

Background:

Various studies have reported that a decision-tree analysis is useful to evaluate different treatment strategies in real clinical practice.

Objective:

The main aim of this study was to research the clinical decisions regarding the treatment of patients who were diagnosed with schizophrenia.

Method:

Cost-effectiveness study of three different interventions to treat patients with schizophrenia were studied. Interventions were divided into the following categories a) day hospital (psycho-educational treatment+psychiatric consultation+psychopharmacological treatment); b) therapy adherence clinic (psychopharmacological treatment with depot antipsychotic medication+psychiatric consultation); c) outpatient psychiatric care (psychopharmacological treatment+psychiatric consultation). For this purpose decision tree model was designed and three outcomes were measured (therapeutic compliance, non-compliance and rehospitalization). TreeAge software was used in order to estimate outcome probabilities and sensitivity analysis, distribution Beta for probabilities and Gamma for cost of interventions.

Results:

The probability of therapeutic compliance and average semestral cost of therapy adherence clinic, outpatient psychiatric care and day hospital are 0.594, 0.284, 2.393, and mean cost intervention US$ 2145.6, US$ 700.2 and US$ 1412.1 respectively (IC95%), according to Montecarlo analysis.

Conclusions:

According to the results, the clinical decision to treat patients in therapy adherence clinic improved therapeutic compliance, but the cost of treatment was higher. There were extra costs and risks to society and patient that are associated with therapeutic non-compliance. It is less expensive for the health care system to provide the patients outpatient psychiatric care, but perhaps in the long-term outpatient psychiatric care is more costly for the patient, their family, and society. According to the many important limitations of this study, further studies are needed to reject/confirm these strategies to be included in real clinical practice
RESUMEN
No disponible
Subject(s)

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Schizophrenia / Cost-Benefit Analysis / 50303 / Medication Adherence Limits: Humans Language: English Journal: Eur. j. psychiatry Year: 2017 Document type: Article Institution/Affiliation country: National Institute of Public Health/Mexico / Psychiatric Hospital "Fray Bernardino Álvarez"/Mexico / University of Guadalajara/Mexico

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Schizophrenia / Cost-Benefit Analysis / 50303 / Medication Adherence Limits: Humans Language: English Journal: Eur. j. psychiatry Year: 2017 Document type: Article Institution/Affiliation country: National Institute of Public Health/Mexico / Psychiatric Hospital "Fray Bernardino Álvarez"/Mexico / University of Guadalajara/Mexico
...